Publications

255 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Periode

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Future scenarios about drug development and drug pricing

This report is the result of a consultative and deliberative process — initiated by the Belgian Healthcare Knowledge Centre (KCE) ...

Report | 28-06-2016

Guideline for economic evaluations in healthcare

This new Guideline unifies all previously available Dutch guidelines, links up with international developments, provides un ...

Guideline | 16-06-2016

Tranylcypromine (Tracydal®) in patients with a severe multi-resistant depressive disorder

Zorginstituut Nederland carried out a budget impact analysis for the medicine tranylcypromine (Tracydal®). They reached the ...

Report | 15-06-2016

Tolperison (Tolpermyo®)

Zorginstituut Nederland has drawn up a pharmacotherapeutic report for the medicine tolperison (Tolpermyo®), whereby it reached ...

Report | 25-05-2016

Brivaracetam (Briviact®)

Zorginstituut Nederland has approved a pharmacotherapeutic report for the medicine brivaracetam (Briviact®), whereby they reached ...

Report | 23-05-2016

Lumacaftor/ivacaftor (Orkambi®) by Cystic fibrosis

Based on the GVS criteria, lumacaftor/ivacaftor (Orkambi®) can not be replaced by another drug in the GVS.  The assessment ...

Report | 13-05-2016

Eculizumab (Soliris®) for the treatment of patients with paroxysmal nocturnal haemogloninuria

Zorginstituut Nederland has re-assessed the medicine eculizumab (Soliris®) for the treatment of patients with paroxysmal ...

Report | 13-05-2016

Levo floxacin (Quinsair®) for the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa

Zorginstituut Nederland carried out a marginal assessment of the medicine levofloxacin (Quinsair®), whereby they came to the ...

Report | 03-05-2016

Early Intensive Neurorehabilitation of adults with unresponsive wakefulness syndrome or a prolonged minimally conscious state

Report | 29-03-2016

Safinamide (Xadago®) for the treatment of adult patients with idiopathic Parkinson's disease

Zorginstituut Nederland has approved a pharmacotherapeutic report for the medicine safinamide (Xadago®). They reached the ...

Report | 21-03-2016